Docking study of transmembrane serine protease type 2 inhibitors for the treatment of COVID-19

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC8988994 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature